BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 28127953)

  • 1. Detection of influenza virus subtype A by polymerase chain reaction: WHO external quality assessment programme summary analysis, 2016.
    Wkly Epidemiol Rec; 2017 Jan; 92(4):37-44. PubMed ID: 28127953
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of influenza virus subtype A by polymerase chain reaction: WHO external quality assessment programme summary analysis, 2015.
    Wkly Epidemiol Rec; 2016 Jan; 91(1):3-11. PubMed ID: 26753194
    [No Abstract]   [Full Text] [Related]  

  • 3. Detection of influenza virus subtype A by polymerase chain reaction: WHO external quality assessment programme summary analysis, 2014.
    Wkly Epidemiol Rec; 2015 Jan; 90(3):9-16. PubMed ID: 25597050
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection of influenza virus subtype A by polymerase chain reaction: WHO external quality assessment programme summary analysis, 2012.
    Wkly Epidemiol Rec; 2013 Jan; 88(4):37-43. PubMed ID: 23393702
    [No Abstract]   [Full Text] [Related]  

  • 5. Detection of influenza virus subtype A by polymerase chain reaction: WHO external quality assessment programme summary analysis, 2013.
    Wkly Epidemiol Rec; 2014 Jan; 89(4/5):37-44. PubMed ID: 24524120
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of a novel bead-based multiplex PCR assay for combined subtyping and oseltamivir resistance genotyping (H275Y) of seasonal and pandemic H1N1 influenza A viruses.
    Mahony JB; Chong S; Luinstra K; Petrich A; Smieja M
    J Clin Virol; 2010 Dec; 49(4):277-82. PubMed ID: 20846903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of influenza viruses by reverse transcription polymerase chain reaction: WHO external quality assessment programme summary analysis, 2017.
    Wkly Epidemiol Rec; 2018 Jan; 93(2):9-16. PubMed ID: 29328559
    [No Abstract]   [Full Text] [Related]  

  • 8. WHO external quality assessment for detecting influenza A virus using polymerase chain reaction – summary, 2010.
    Wkly Epidemiol Rec; 2011 Jan; 86(3):17-24. PubMed ID: 21243827
    [No Abstract]   [Full Text] [Related]  

  • 9. Surveillance for neuraminidase inhibitor resistance in human influenza viruses from Australia.
    Hurt AC; Barr IG; Durrant CJ; Shaw RP; Sjogren HM; Hampson AW
    Commun Dis Intell Q Rep; 2003; 27(4):542-7. PubMed ID: 15508516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza virus susceptibility and resistance to oseltamivir.
    Aoki FY; Boivin G; Roberts N
    Antivir Ther; 2007; 12(4 Pt B):603-16. PubMed ID: 17944268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza A viruses of swine circulating in the United States during 2009-2014 are susceptible to neuraminidase inhibitors but show lineage-dependent resistance to adamantanes.
    Baranovich T; Bahl J; Marathe BM; Culhane M; Stigger-Rosser E; Darnell D; Kaplan BS; Lowe JF; Webby RJ; Govorkova EA
    Antiviral Res; 2015 May; 117():10-9. PubMed ID: 25701593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WHO external quality assessment project for detecting influenza virus subtype A by polymerase chain reaction - summary analysis, 2009.
    Wkly Epidemiol Rec; 2009 Nov; 84(48):493-500. PubMed ID: 19960621
    [No Abstract]   [Full Text] [Related]  

  • 13. Detection of influenza virus subtype A by polymerase chain reaction: WHO external quality assessment project summary analysis, 2011.
    Wkly Epidemiol Rec; 2012 Jan; 87(3):29-35. PubMed ID: 24340393
    [No Abstract]   [Full Text] [Related]  

  • 14. WHO external quality assessment project for the detection of subtype influenza A viruses by polymerase chain reaction--summary analysis, 2007 and 2008.
    Wkly Epidemiol Rec; 2008 Nov; 83(45):401-12. PubMed ID: 18990792
    [No Abstract]   [Full Text] [Related]  

  • 15. Review of the clinical effectiveness of the neuraminidase inhibitors against influenza B viruses.
    Farrukee R; Mosse J; Hurt AC
    Expert Rev Anti Infect Ther; 2013 Nov; 11(11):1135-45. PubMed ID: 24093683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuraminidase inhibitor susceptibility testing of influenza type B viruses in China during 2010 and 2011 identifies viruses with reduced susceptibility to oseltamivir and zanamivir.
    Wang D; Sleeman K; Huang W; Nguyen HT; Levine M; Cheng Y; Li X; Tan M; Xing X; Xu X; Klimov AI; Gubareva LV; Shu Y
    Antiviral Res; 2013 Mar; 97(3):240-4. PubMed ID: 23267831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed influenza A and B infections complicate the detection of influenza viruses with altered sensitivities to neuraminidase inhibitors.
    Mohr PG; Geyer H; McKimm-Breschkin JL
    Antiviral Res; 2011 Jul; 91(1):20-2. PubMed ID: 21549758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance of influenza isolates for susceptibility to neuraminidase inhibitors during the 2000-2002 influenza seasons.
    Mungall BA; Xu X; Klimov A
    Virus Res; 2004 Jul; 103(1-2):195-7. PubMed ID: 15163509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meeting of the WHO working group on polymerase chain reaction protocols for detecting subtype influenza A viruses – Geneva, June 2010.
    Wkly Epidemiol Rec; 2010 Nov; 85(46):453-7. PubMed ID: 21090390
    [No Abstract]   [Full Text] [Related]  

  • 20. Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivir.
    Hurt AC; Barr IG; Hartel G; Hampson AW
    Antiviral Res; 2004 Apr; 62(1):37-45. PubMed ID: 15026200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.